Provider
QP95-19 New Drug, Reyvow™ (lasmiditan) Will Require Prior Authorization (PA)
Program effective Date: Nov 27, 2019
Documents & Forms Results
Displaying 2441 - 2450 of 3111 results
Provider
QP93-19 Provider Cost Data Update
Program effective Date: Nov 27, 2019
Provider
QP99-19 Pharmacy Benefit Exclusion for Rapatha ®
Program effective Date: Nov 27, 2019
Provider
QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid
Program effective Date: Nov 27, 2019
Provider
QP94-19 MDH Syphilis Pregnancy Screening Guidelines
Program effective Date: Nov 27, 2019
Provider
QP101-19 InterQual ® Level of Care Criteria for Concurrent Review Authorizations
Program effective Date: Nov 27, 2019
Provider
QP100-19 Blue Distinction Center and Blue Distinction Center + Designations Being Applied to Ambulatory Surgical Centers for Spine, Knee and Hip Services
Program effective Date: Nov 27, 2019
Provider
QP97-19 Commercial Product Changes for 2020
Program effective Date: Nov 27, 2019
Provider
QP98-19 Changes to Blue Cross Mailing Addresses
Program effective Date: Nov 27, 2019
Provider
2019 December Provider Press
Program effective Date: Nov 21, 2019